| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |